-
Beam Therapeutics (NASDAQ:BEAM) Rating Increased to Sector Outperform at Scotiabank
Source: Buzz FX / 11 Mar 2025 12:31:15 America/New_York
Beam Therapeutics (NASDAQ:BEAM) Rating Increased to Sector Outperform at Scotiabank Written by MarketBeat March 11, 2025 Share Link copied to clipboard. Remove Ads Beam Therapeutics ( NASDAQ:BEAM - Get Free Report ) was upgraded by research
Read more...